Caplacizumab

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 403 publications

Caplacizumab-Enabled Treatment of Immune-Mediated Thrombotic Thrombocytopenic Purpura Without Plasma Exchange: Evidence, Patient Selection, and Practical Considerations.

Caplacizumab-Enabled Treatment of Immune-Mediated Thrombotic Thrombocytopenic Purpura Without Plasma Exchange: Evidence, Patient Selection, and Practical Considerations.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: August 03, 2026

Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura.

Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura.

Journal: Thrombosis and haemostasis
Published: July 15, 2026

Severe Immune-Mediated Thrombotic Thrombocytopenic Purpura With High-Titer ADAMTS13 Inhibitors: A Case Report.

Severe Immune-Mediated Thrombotic Thrombocytopenic Purpura With High-Titer ADAMTS13 Inhibitors: A Case Report.

Journal: Cureus
Published: July 13, 2026

Acquired immune-mediated thrombotic thrombocytopenic purpura with severe cholestatic liver injury and reversible acute kidney injury after ivonescimab-containing chemoimmunotherapy: a case report and literature review.

Acquired immune-mediated thrombotic thrombocytopenic purpura with severe cholestatic liver injury and reversible acute kidney injury after ivonescimab-containing chemoimmunotherapy: a case report and literature review.

Journal: Frontiers in immunology
Published: June 13, 2026

Immune-Mediated Thrombotic Thrombocytopenic Purpura in a Patient With Systemic Lupus Erythematosus and Recent Epstein-Barr Virus Infection: A Diagnostic Challenge.

Immune-Mediated Thrombotic Thrombocytopenic Purpura in a Patient With Systemic Lupus Erythematosus and Recent Epstein-Barr Virus Infection: A Diagnostic Challenge.

Journal: Cureus
Published: May 31, 2026

N-acetylcysteine in Thrombotic Thrombocytopenic Purpura: A Systematic Review.

N-acetylcysteine in Thrombotic Thrombocytopenic Purpura: A Systematic Review.

Journal: Cureus
Published: May 23, 2026

Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center.

Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center.

Journal: Hematology reports
Published: May 12, 2026

Neurological Impact of Caplacizumab in Refractory iTTP Survivors: A Comparative Study of Blood-Brain-Barrier Integrity and Cognitive Outcomes.

Neurological Impact of Caplacizumab in Refractory iTTP Survivors: A Comparative Study of Blood-Brain-Barrier Integrity and Cognitive Outcomes.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 07, 2026

Real-world evolution of therapeutic strategies and outcomes in acquired thrombotic thrombocytopenic purpura: a 14-year referral center experience.

Real-world evolution of therapeutic strategies and outcomes in acquired thrombotic thrombocytopenic purpura: a 14-year referral center experience.

Journal: Medicina clinica
Published: May 06, 2026

A paradoxically decreased von Willebrand factor activity that should not be overlooked

A paradoxically decreased von Willebrand factor activity that should not be overlooked

Journal: Annales de biologie clinique
Published: April 30, 2026

The modern role of corticosteroids in immune thrombotic thrombocytopenic purpura.

The modern role of corticosteroids in immune thrombotic thrombocytopenic purpura.

Journal: Annals of blood
Published: April 22, 2026

Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review

Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: April 16, 2026
Showing 1-12 of 403

Last Updated: 09/26/2026